IK and Carlyle's Marle buys SMB

SMB said the consolidated business will have an extended product range and broader geographic presence.

IK bought a majority stake in Marle from Carlyle in May 2016, drawing capital from the fund IK VII for a deal worth approximately €350m. Carlyle remained invested after the transaction, reducing its stake from around 80% to around 20% while the Marle family retained 20% and IK took around 60%.

Under Carlyle's ownership Marle made several acquisitions in France, including SEEP, ATS and Sferic in 2011, as well as Finortho in 2015.

Marle generated revenues of €82m in 2015 with EBITDA of €25m.

Company
SMB is a Swiss orthopaedic implant manufacturer based in Sant'Antonino. It is a contract manufacturer that produces implants in all available medical alloys. To date, SMB has forged 2.5 million hip and knee implants. The firm employs 85 people.

People
IK Investment Partners – Rémi Buttiaux (partner).
Marle International – Antonio Gil (CEO).
SMB Medical – Heimo Wabusseg (CEO).

Advisers
Equity – Quarton International (M&A).

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Portfolio management
• DACH
• Healthcare
• Carlyle Group
• IK Investment Partners
• Germany